Device Center Enthusiastic About Bayesian Trial Submissions
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center continues to ramp up its resources to deal with a potential influx of PMA submissions that rely on an advanced statistical technique that can speed up clinical trials